Kisspeptin (10mg Vial) Dosage Protocol
Table of Contents
Quickstart Highlights
Kisspeptin (also known as metastin) is a naturally occurring neuroendocrine peptide that plays a pivotal role in human reproduction by stimulating gonadotropin-releasing hormone (GnRH) secretion[1]. This small peptide binds to the GPR54 receptor in the hypothalamus, triggering pulsatile GnRH release and downstream secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH)[2]. Originally identified as a metastasis-suppressor gene product, kisspeptin has become a major focus in reproductive endocrinology[3]. This educational protocol presents a once-daily subcutaneous approach for research use.
- Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
- Typical daily range: 100–200 mcg once daily (gradual titration).
- Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution,refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Dosing & Reconstitution Guide
Educational guide for reconstitution and dosing protocol
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 3 units (0.03 mL) |
| Weeks 3–8 | 200 mcg | 6 units (0.06 mL) |
Frequency: Inject once daily subcutaneously. This schedule follows a conservative titration to assess individual response[4][5]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Protocol Overview
Concise summary of the once‑daily regimen.
- Goal : Support physiological reproductive hormone signaling through upstream GnRH stimulation[1].
- Schedule : Daily subcutaneous injections for 8–12 weeks.
- Dose Range : 100–200 mcg daily with gradual titration.
- Reconstitution : 3.0 mL per 10 mg vial (~3.33 mg/mL) for precise low-volume measurements.
- Storage : Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested daily titration approach.
- Start : 100 mcg daily for 1–2 weeks to assess sensitivity[4].
- Titrate: Increase to 200 mcg daily if tolerated and necessary[5].
- Frequency: Once per day (subcutaneous).
- Cycle Length: 8–12 weeks; avoid prolonged continuous use to prevent tachyphylaxis[6].
- Timing: Any consistent time; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions with desiccant if possible[15].
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); stable up to ~4 weeks[16]; avoid freeze–thaw.
- Allow vials to reach room temperature before opening to reduce condensation uptake.
Suppilies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
- Peptide Vials (Kisspeptin, 10 mg each):
-
- 8 weeks ≈ 1 vial
- 12 weeks ≈ 2 vials
- 16 weeks ≈ 3 vials
- Insulin Syringes (U-100): </b
-
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
- Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.:
-
- 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
- 12 weeks (2 vials): 6 mL → 1 × 10 mL bottle
- 16 weeks (3 vials): 9 mL → 1 × 10 mL bottle
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
-
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Important Notes
Concise summary of the once‑daily regimen.
- Goal: Support physiological reproductive hormone signaling through upstream GnRH stimulation[1].
- Schedule: Daily subcutaneous injections for 8–12 weeks.
- Dose Range: 100–200 mcg daily with gradual titration.
- Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for precise low-volume measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
How This Works
Kisspeptin is an upstream trigger for the reproductive hormone cascade. Upon subcutaneous injection, kisspeptin rapidly binds to kisspeptin receptors (GPR54) on GnRH neurons in the hypothalamus, causing immediate release of GnRH[7]. This in turn stimulates the anterior pituitary to secrete LH and FSH, which act on the gonads to boost sex steroid production and support gametogenesis[8]. Importantly, kisspeptin’s action is GnRH-dependent—if GnRH release is blocked, kisspeptin cannot induce LH/FSH secretion[9]. This confirms that kisspeptin works by unlocking the body’s own GnRH stores, providing a more physiologic pattern of hormone release compared to direct GnRH or hCG administration[10].
Potential Benefits & Side Effects
Research on kisspeptin has revealed multiple potential benefits for reproductive health.
- Physiological Sex Hormone Stimulation: Increases endogenous testosterone and estrogen levels by amplifying the body’s own LH/FSH signals without suppressing the HPG axis[11].
- Fertility Restoration: Shows promise in functional hypothalamic amenorrhea by rekindling GnRH/LH pulsatility and resuming menstrual cycles[12].
- IVF Ovulation Trigger: Can induce robust LH surge to mature oocytes while potentially lowering the risk of ovarian hyperstimulation syndrome compared to traditional hCG triggers[13][14].
- Safety Profile: Generally well tolerated; occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.
Lifestyle Factors
Complementary strategies for optimal outcomes.
- Maintain adequate nutrition and healthy body weight to support endogenous hormone production.
- Prioritize sleep and stress management, as these factors significantly impact the HPG axis.
- Monitor for changes in reproductive function or hormone-related symptoms.
- Consider combining with appropriate lifestyle interventions for conditions of hypothalamic suppression.
Injection Technique
General subcutaneous guidance from clinical best‑practice resources.
- Clean the vial stopper and skin with alcohol; allow to dry completely.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue (45° for thin individuals, 90° with adequate fat)[18].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[19].
- Rotate sites systematically (abdomen at least 2 inches from navel, outer thighs, upper arms, upper buttocks) to avoid tissue irritation[13].
- Use a new sterile syringe for each injection; dispose of used syringes in a proper sharps container[20].
Recommended Source
We recommend Go Alpha Labsfor high‑purity Kisspeptin (10 mg).
Why Go Alpha Labs?
- Verifies ≥99% purity through independent lab testing
- Trusted by researchers seeking reliable results
- Follows rigorous manufacturing standards for consistent quality
Important Note:
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.
References:
| Source | Link |
|---|---|
| Endocrine Reviews (Oxford Academic) – Emerging Therapeutic Potential of Kisspeptin and Neurokinin B | View Source |
| Endocrine Reviews (Oxford Academic) – Kisspeptin stimulation of GnRH and downstream LH/FSH secretion | View Source |
| Endocrine Reviews (Oxford Academic) – KiSS-1 gene discovery and role in metastasis suppression | View Source |
| Kisspeptin-10 Clinical Reference Sheet – Starting dose recommendations and titration guidance | View Source |
| Endocrine Reviews (Oxford Academic) – Dose-response relationships and titration protocols | View Source |
| Endocrine Reviews (Oxford Academic) – Tachyphylaxis considerations with prolonged kisspeptin exposure | View Source |
| Endocrine Reviews (Oxford Academic) – Kisspeptin mechanism: GPR54 receptor binding and GnRH release | View Source |
| Endocrine Reviews (Oxford Academic) – HPG axis cascade: GnRH stimulation of pituitary LH/FSH | View Source |
| Endocrine Reviews (Oxford Academic) – GnRH-dependent action of kisspeptin (antagonist studies) | View Source |
| Endocrine Reviews (Oxford Academic) – Physiologic advantage of kisspeptin vs. direct GnRH/hCG | View Source |
| Kisspeptin-10 Clinical Reference Sheet – Endogenous testosterone increases via LH pathway | View Source |
| Endocrine Reviews (Oxford Academic) – Functional hypothalamic amenorrhea: restoration of GnRH pulsatility | View Source |
| Journal of Clinical Investigation – Kisspeptin-54 triggers egg maturation in IVF with reduced OHSS risk | View Source |
| Endocrine Reviews (Oxford Academic) – Ovulation trigger applications and OHSS prevention | View Source |
| Prospec Bio – Lyophilized peptide storage recommendations | View Source |
| Peptide Systems – Research peptide reconstitution and stability protocols | View Source |
| Empower Pharmacy – Bacteriostatic Water handling and 28-day discard guidelines | View Source |
| Clinical Procedures for Safer Patient Care – Subcutaneous injection technique: angle and site guidance | View Source |
| CDC Vaccine Administration Guidelines – Subcutaneous route: no aspiration required | View Source |
| NCBI Bookshelf – Parenteral medication administration: sterile technique and disposal | View Source |
| Pure Lab Peptides – Kisspeptin (10 mg) product page (quality and batch documentation) | View Source |